Structure and immune recognition of trimeric pre-fusion HIV-1 Env
|
journal
|
October 2014 |
Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env
|
journal
|
June 2015 |
Dilation of the Human Immunodeficiency Virus–1 Envelope Glycoprotein Fusion Pore Revealed by the Inhibitory Action of a Synthetic Peptide from gp41
|
journal
|
January 1998 |
A Trimeric Structural Subdomain of the HIV-1 Transmembrane Glycoprotein
|
journal
|
December 1997 |
Immunogenic Presentation of a Conserved gp41 Epitope of Human Immunodeficiency Virus Type 1 on Recombinant Surface Antigen of Hepatitis B Virus
|
journal
|
September 1996 |
Structure of an unliganded simian immunodeficiency virus gp120 core
|
journal
|
February 2005 |
New methods for indexing multi-lattice diffraction data
|
journal
|
September 2014 |
Molecular Architectures of Trimeric SIV and HIV-1 Envelope Glycoproteins on Intact Viruses: Strain-Dependent Variation in Quaternary Structure
|
journal
|
December 2010 |
Atomic structure of the ectodomain from HIV-1 gp41
|
journal
|
May 1997 |
HIV-1 Envelope Glycoprotein Biosynthesis, Trafficking, and Incorporation
|
journal
|
July 2011 |
Characterization of the steric defense of the HIV‐1 gp41 N‐trimer region
|
journal
|
December 2008 |
Asymmetric Deactivation of HIV-1 gp41 following Fusion Inhibitor Binding
|
journal
|
November 2009 |
Epitope Mapping and Topology of Baculovirus-Expressed HIV-1 gp160 Determined with a Panel of Murine Monoclonal Antibodies
|
journal
|
April 1994 |
Membrane Fusion Mediated by Human Immunodeficiency Virus Envelope Glycoprotein
|
book
|
January 2011 |
Dissociation of gp120 from HIV-1 virions induced by soluble CD4
|
journal
|
November 1990 |
A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope
|
journal
|
October 2005 |
Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.
|
journal
|
October 1994 |
Subunit Stoichiometry of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Trimers during Virus Entry into Host Cells
|
journal
|
April 2006 |
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
|
journal
|
June 1998 |
Vaccination with peptide mimetics of the gp41 prehairpin fusion intermediate yields neutralizing antisera against HIV-1 isolates
|
journal
|
May 2010 |
Identification of a major co-receptor for primary isolates of HIV-1
|
journal
|
June 1996 |
Cooperative subunit interactions within the oligomeric envelope glycoprotein of HIV-1: Functional complementation of specific defects in gp120 and gp41
|
journal
|
October 2000 |
How good are my data and what is the resolution?
|
journal
|
June 2013 |
Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer
|
journal
|
October 2013 |
Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer
|
journal
|
October 2013 |
Evidence That the Transition of HIV-1 Gp41 into a Six-Helix Bundle, Not the Bundle Configuration, Induces Membrane Fusion
|
journal
|
October 2000 |
Is there a future for antiviral fusion inhibitors?
|
journal
|
February 2012 |
HIV-1 gp41 as a Target for Viral Entry Inhibition
|
journal
|
June 2004 |
Early Steps of HIV-1 Fusion Define the Sensitivity to Inhibitory Peptides That Block 6-Helix Bundle Formation
|
journal
|
September 2009 |
HIV-1 Envelope Proteins Complete Their Folding into Six-helix Bundles Immediately after Fusion Pore Formation
|
journal
|
March 2003 |
MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1
|
journal
|
February 2011 |
Affinity maturation and characterization of a human monoclonal antibody against HIV-1 gp41
|
journal
|
September 2009 |
Core Structure of gp41 from the HIV Envelope Glycoprotein
|
journal
|
April 1997 |
Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics
|
journal
|
November 2002 |
CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5
|
journal
|
November 1996 |
Thermodynamic Stability of the Asymmetric Doubly-Ligated Hemoglobin Tetramer (α +CN β +CN )(αβ): Methodological and Mechanistic Issues †
|
journal
|
September 1997 |
Affinity maturation by targeted diversification of the CDR-H2 loop of a monoclonal Fab derived from a synthetic naïve human antibody library and directed against the internal trimeric coiled-coil of gp41 yields a set of Fabs with improved HIV-1 neutralization potency and breadth
|
journal
|
October 2009 |
Antibody elicited against the gp41 N-heptad repeat (NHR) coiled-coil can neutralize HIV-1 with modest potency but non-neutralizing antibodies also bind to NHR mimetics
|
journal
|
July 2008 |
Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G
|
journal
|
May 2016 |
Viral membrane fusion
|
journal
|
July 2008 |
Interaction of the gp120 V1V2 loop with a neighboring gp120 unit shields the HIV envelope trimer against cross-neutralizing antibodies
|
journal
|
June 2011 |
CHEMOKINE RECEPTORS AS HIV-1 CORECEPTORS: Roles in Viral Entry, Tropism, and Disease
|
journal
|
April 1999 |
Coot model-building tools for molecular graphics
|
journal
|
November 2004 |
Complementation of diverse HIV-1 Env defects through cooperative subunit interactions: a general property of the functional trimer
|
journal
|
August 2009 |
Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target
|
journal
|
December 1998 |
Fusion Peptides Derived from the HIV Type 1 Glycoprotein 41 Associate within Phospholipid Membranes and Inhibit Cell-Cell Fusion: STRUCTURE-FUNCTION STUDY
|
journal
|
May 1997 |
Spectroscopic Determination of Tryptophan and Tyrosine in Proteins *
|
journal
|
July 1967 |
Protein Design of an HIV-1 Entry Inhibitor
|
journal
|
January 2001 |
Kinetic Factors Control Efficiencies of Cell Entry, Efficacies of Entry Inhibitors, and Mechanisms of Adaptation of Human Immunodeficiency Virus
|
journal
|
March 2005 |
Capture of an early fusion-active conformation of HIV-1 gp41
|
journal
|
April 1998 |
The Role of Antibody Polyspecificity and Lipid Reactivity in Binding of Broadly Neutralizing Anti-HIV-1 Envelope Human Monoclonal Antibodies 2F5 and 4E10 to Glycoprotein 41 Membrane Proximal Envelope Epitopes
|
journal
|
March 2007 |
Molecular architecture of native HIV-1 gp120 trimers
|
journal
|
July 2008 |
Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding.
|
journal
|
August 1991 |
Biochemistry and Biophysics of HIV-1 gp41 - Membrane Interactions and Implications for HIV-1 Envelope Protein Mediated Viral-Cell Fusion and Fusion Inhibitor Design
|
journal
|
December 2011 |
Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution
|
journal
|
January 1981 |
Cryo-Electron Tomographic Structure of an Immunodeficiency Virus Envelope Complex In Situ
|
journal
|
January 2006 |
Inhibiting HIV-1 Entry
|
journal
|
October 1999 |
The role of the N-terminal segment of CCR5 in HIV-1 Env-mediated membrane fusion and the mechanism of virus adaptation to CCR5 lacking this segment
|
journal
|
January 2007 |
Mechanisms of Viral Membrane Fusion and Its Inhibition
|
journal
|
June 2001 |
Crystal Structure of HIV-1 gp41 Including Both Fusion Peptide and Membrane Proximal External Regions
|
journal
|
May 2010 |
Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer
|
journal
|
March 2016 |
A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition.
|
journal
|
November 1992 |
Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor
|
journal
|
July 2008 |
Design of a Potent D-Peptide HIV-1 Entry Inhibitor with a Strong Barrier to Resistance
|
journal
|
August 2010 |
HIV Entry and Its Inhibition
|
journal
|
May 1998 |
Phaser crystallographic software
|
journal
|
July 2007 |
HIV-1 inhibition by a peptide
|
journal
|
September 1993 |
Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding.
|
journal
|
January 1990 |
Design and Properties of N CCG -gp41, a Chimeric gp41 Molecule with Nanomolar HIV Fusion Inhibitory Activity
|
journal
|
June 2001 |
Early Intermediates in HIV-1 Envelope Glycoprotein-mediated Fusion Triggered by CD4 and Co-receptor Complexes
|
journal
|
June 2001 |
Kinetic Dependence to HIV-1 Entry Inhibition
|
journal
|
June 2006 |
Interactions of HIV-1 Inhibitory Peptide T20 with the gp41 N-HR Coiled Coil
|
journal
|
December 2008 |
Asymmetric Cooperativity in a Symmetric Tetramer: Human Hemoglobin
|
journal
|
January 2006 |
Receptor-Mediated Activation of Immunodeficiency Viruses in Viral Fusion
|
journal
|
May 1991 |
A Monoclonal Fab Derived from a Human Nonimmune Phage Library Reveals a New Epitope on gp41 and Neutralizes Diverse Human Immunodeficiency Virus Type 1 Strains
|
journal
|
September 2007 |
Clinical Resistance to Enfuvirtide Does Not Affect Susceptibility of Human Immunodeficiency Virus Type 1 to Other Classes of Entry Inhibitors
|
journal
|
January 2007 |
Crystal Structure of Unliganded Influenza B Virus Hemagglutinin
|
journal
|
January 2008 |
Three-Dimensional Structures of Soluble CD4-Bound States of Trimeric Simian Immunodeficiency Virus Envelope Glycoproteins Determined by Using Cryo-Electron Tomography
|
journal
|
September 2011 |
Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: effects on infectivity and neutralization.
|
journal
|
January 1991 |
Direct measurement of soluble CD4 binding to human immunodeficiency virus type 1 virions: gp120 dissociation and its implications for virus-cell binding and fusion reactions and their neutralization by soluble CD4.
|
journal
|
January 1991 |
Effects of changes in gp120-CD4 binding affinity on human immunodeficiency virus type 1 envelope glycoprotein function and soluble CD4 sensitivity.
|
journal
|
January 1991 |
Distinct modes of human immunodeficiency virus type 1 proviral latency revealed by superinfection of nonproductively infected cell lines with recombinant luciferase-encoding viruses.
|
journal
|
January 1994 |
Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype.
|
journal
|
January 1997 |
Macrophage tropism of human immunodeficiency virus type 1 and utilization of the CC-CKR5 coreceptor.
|
journal
|
January 1997 |
Direct Evidence that C-Peptide Inhibitors of Human Immunodeficiency Virus Type 1 Entry Bind to the gp41 N-Helical Domain in Receptor-Activated Viral Envelope
|
journal
|
July 2003 |
Impact of Mutations in the Coreceptor Binding Site on Human Immunodeficiency Virus Type 1 Fusion, Infection, and Entry Inhibitor Sensitivity
|
journal
|
April 2004 |
Emergence of a Drug-Dependent Human Immunodeficiency Virus Type 1 Variant during Therapy with the T20 Fusion Inhibitor
|
journal
|
October 2004 |
The Cytoplasmic Tail Slows the Folding of Human Immunodeficiency Virus Type 1 Env from a Late Prebundle Configuration into the Six-Helix Bundle
|
journal
|
December 2004 |
Variants of Human Immunodeficiency Virus Type 1 That Efficiently Use CCR5 Lacking the Tyrosine-Sulfated Amino Terminus Have Adaptive Mutations in gp120, Including Loss of a Functional N-Glycan
|
journal
|
March 2005 |
Structure and immune recognition of trimeric pre-fusion HIV-1 Env
|
text
|
January 2014 |